ACCRUED EXPENSES

12 Months Ended

Dec. 31, 2020

8.	ACCRUED EXPENSES

Accrued expenses consisted of the following:

SCHEDULE OF ACCRUED EXPENSES

	2020		2019
	December 31,
	2020		2019
Accrued clinical operations and trials costs	$	14,132,842	$	14,242,669
Accrued product development costs		2,189,047		3,573,231
Accrued compensation		4,222,594		3,673,111
Accrued other		1,460,949		958,928
Total	$	22,005,432	$	22,447,939